289 related articles for article (PubMed ID: 17767155)
1. Robust immune responses elicited by a fully synthetic three-component vaccine.
Ingale S; Wolfert MA; Gaekwad J; Buskas T; Boons GJ
Nat Chem Biol; 2007 Oct; 3(10):663-7. PubMed ID: 17767155
[TBL] [Abstract][Full Text] [Related]
2. Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors.
Ingale S; Wolfert MA; Buskas T; Boons GJ
Chembiochem; 2009 Feb; 10(3):455-63. PubMed ID: 19145607
[TBL] [Abstract][Full Text] [Related]
3. Design of fully synthetic, self-adjuvanting vaccine incorporating the tumor-associated carbohydrate Tn antigen and lipoamino acid-based Toll-like receptor 2 ligand.
Abdel-Aal AB; El-Naggar D; Zaman M; Batzloff M; Toth I
J Med Chem; 2012 Aug; 55(15):6968-74. PubMed ID: 22800462
[TBL] [Abstract][Full Text] [Related]
4. A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates.
Lo-Man R; Vichier-Guerre S; Perraut R; Dériaud E; Huteau V; BenMohamed L; Diop OM; Livingston PO; Bay S; Leclerc C
Cancer Res; 2004 Jul; 64(14):4987-94. PubMed ID: 15256473
[TBL] [Abstract][Full Text] [Related]
5. Syntheses and Immunological Evaluation of Self-Adjuvanting Clustered N-Acetyl and N-Propionyl Sialyl-Tn Combined with a T-helper Cell Epitope as Antitumor Vaccine Candidates.
Chang TC; Manabe Y; Fujimoto Y; Ohshima S; Kametani Y; Kabayama K; Nimura Y; Lin CC; Fukase K
Angew Chem Int Ed Engl; 2018 Jul; 57(27):8219-8224. PubMed ID: 29768704
[TBL] [Abstract][Full Text] [Related]
6. Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.
Sørensen AL; Reis CA; Tarp MA; Mandel U; Ramachandran K; Sankaranarayanan V; Schwientek T; Graham R; Taylor-Papadimitriou J; Hollingsworth MA; Burchell J; Clausen H
Glycobiology; 2006 Feb; 16(2):96-107. PubMed ID: 16207894
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Immunological Evaluation of Disaccharide Bearing MUC-1 Glycopeptide Conjugates with Virus-like Particles.
Wu X; McKay C; Pett C; Yu J; Schorlemer M; Ramadan S; Lang S; Behren S; Westerlind U; Finn MG; Huang X
ACS Chem Biol; 2019 Oct; 14(10):2176-2184. PubMed ID: 31498587
[TBL] [Abstract][Full Text] [Related]
8. A fully synthetic four-component antitumor vaccine consisting of a mucin glycopeptide antigen combined with three different T-helper-cell epitopes.
Palitzsch B; Hartmann S; Stergiou N; Glaffig M; Schmitt E; Kunz H
Angew Chem Int Ed Engl; 2014 Dec; 53(51):14245-9. PubMed ID: 25318465
[TBL] [Abstract][Full Text] [Related]
9. Immune and anticancer responses elicited by fully synthetic aberrantly glycosylated MUC1 tripartite vaccines modified by a TLR2 or TLR9 agonist.
Abdel-Aal AB; Lakshminarayanan V; Thompson P; Supekar N; Bradley JM; Wolfert MA; Cohen PA; Gendler SJ; Boons GJ
Chembiochem; 2014 Jul; 15(10):1508-13. PubMed ID: 24890740
[TBL] [Abstract][Full Text] [Related]
10. The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity.
Laubreton D; Bay S; Sedlik C; Artaud C; Ganneau C; Dériaud E; Viel S; Puaux AL; Amigorena S; Gérard C; Lo-Man R; Leclerc C
Cancer Immunol Immunother; 2016 Mar; 65(3):315-25. PubMed ID: 26847142
[TBL] [Abstract][Full Text] [Related]
11. Towards a fully synthetic carbohydrate-based anticancer vaccine: synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated tn antigen.
Buskas T; Ingale S; Boons GJ
Angew Chem Int Ed Engl; 2005 Sep; 44(37):5985-8. PubMed ID: 16108081
[No Abstract] [Full Text] [Related]
12. Anti-tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a tri-Tn glycotope.
Lo-Man R; Vichier-Guerre S; Bay S; Dériaud E; Cantacuzène D; Leclerc C
J Immunol; 2001 Feb; 166(4):2849-54. PubMed ID: 11160353
[TBL] [Abstract][Full Text] [Related]
13. Induction of carbohydrate-specific antibodies in HLA-DR transgenic mice by a synthetic glycopeptide: a potential anti cancer vaccine for human use.
Vichier-Guerre S; Lo-Man R; BenMohamed L; Dériaud E; Kovats S; Leclerc C; Bay S
J Pept Res; 2003 Sep; 62(3):117-24. PubMed ID: 12895273
[TBL] [Abstract][Full Text] [Related]
14. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
15. MUC1-derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast cancer tissue.
Gad M; Jensen T; Gagne R; Komba S; Daugaard S; Kroman N; Meldal M; Werdelin O
Eur J Immunol; 2003 Jun; 33(6):1624-32. PubMed ID: 12778480
[TBL] [Abstract][Full Text] [Related]
16. T-cell recognition of tumor-associated carbohydrates: the nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity.
Galli-Stampino L; Meinjohanns E; Frische K; Meldal M; Jensen T; Werdelin O; Mouritsen S
Cancer Res; 1997 Aug; 57(15):3214-22. PubMed ID: 9242452
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity study of Globo H analogues with modification at the reducing or nonreducing end of the tumor antigen.
Lee HY; Chen CY; Tsai TI; Li ST; Lin KH; Cheng YY; Ren CT; Cheng TJ; Wu CY; Wong CH
J Am Chem Soc; 2014 Dec; 136(48):16844-53. PubMed ID: 25371992
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the immunogenicity of synthetic carbohydrate vaccines by chemical modifications of STn antigen.
Yang F; Zheng XJ; Huo CX; Wang Y; Zhang Y; Ye XS
ACS Chem Biol; 2011 Mar; 6(3):252-9. PubMed ID: 21121644
[TBL] [Abstract][Full Text] [Related]
19. Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies.
Ragupathi G; Deshpande PP; Coltart DM; Kim HM; Williams LJ; Danishefsky SJ; Livingston PO
Int J Cancer; 2002 May; 99(2):207-12. PubMed ID: 11979435
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of an anticancer vaccine containing the C-glycoside analogue of the Tn epitope.
Peri F; Cipolla L; Rescigno M; La Ferla B; Nicotra F
Bioconjug Chem; 2001; 12(3):325-8. PubMed ID: 11353527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
